📑 Do pts w cirrhosis +/- MHE have longer reaction times (RT) in a newly developed virtual reality driving test⁉️

Prospective Study:
👉Pts w MHE had longer RTs compared to no MHE or controls
👉Longer RT asscoiated w ⬆️ car accidents/🛑 driving due to HE

journals.lww.com/hepcomm/fullte…

Please join us Thursday morning 7:30am ET to hear the great Nadim Mahmud discuss pre operative risk assessment in cirrhosis!

His work in this space has been transformative.

A #livertwitter can’t miss event!

umich.zoom.us/meeting/regist…

Genetics of liver disease

Phenomenal review covering everything you need to know about the role of genetics in diseases common and rare and whom to sequence / test

Open access journals.lww.com/hepcomm/fullte…

#livertwitter

This is the best review on granulomatous liver diseases

Open access: journals.lww.com/hepcomm/fullte…

epidemiology, diagnosis, pathology, and management

#livertwitter

The ELS Program provides medical residents the opportunity to explore #hepatology as a career by offering educational and professional development, learning from leading hepatologists around the world, and much more! Be part of the next ELS class: aasldfoundation.org/awards-program…

Thank you Joint CDDW™-CLM Conference 2024 | #CDDWCLM2024 for inviting me to beautiful Toronto to talk about speech as a biomarker for HE!

BONUS: getting to hear about the amazing work my friend Jin Ge is up to using LLMs to revolutionize hepatology care

📢 Join us for the fifth ISHEN translational presentation series:

🗓️ When: March 12th 2024

✅ Invited speakers:
- Prof. Cornelius Englemann Cornelius Engelmann
- Prof. Constantine (Dean) Karvellas Dean Karvellas

⬇️ Registration ⬇️
epfl.zoom.us/meeting/regist…

📑 Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study

🟢 Well-tolerated
🟢 ⬇️ portal systemic shunt fraction in CP-A cirrhosis
#LiverTwitter

journals.lww.com/hepcomm/fullte…

The safety and efficacy of biologic therapy among people with primary sclerosing cholangitis and IBD

👍endoscopic response
😢no improvement in cholestasis
🧐⬆️ enzymes on vedo?

Open access: journals.lww.com/hepcomm/fullte… #gitwitter #livertwitter
First author: Dr Ayesha Shah

Was honored to be invited to participate in this great piece

Finally got to write something with my microbiome hepatology hero Jasmohan Bajaj 🤩🌟❗️

🌟The Hepatology Communications Editors would like to acknowledge and thank the journal's top peer reviewers for 2023🌟
THANK YOU to our top reviewers and all reviewers!

If you have not heard THE Ashley Spann talk, I insist that you invite her for grand rounds at your institution. At #TLM23 , she was an 'implementation hero'. Tomorrow, she presents at Michigan Hepatology grand rounds. #livertwitter

We hear a lot about 'leaky gut' in cirrhosis, but which gut segment is leaky and are certain bacteria 🧫 associated with leaky gut⁉️
 
Duodenum is the leakiest segment in cirrhosis, and certain bacteria are associated with leaky gut❕
  #LiverTwitter

journals.lww.com/hepcomm/fullte…

Tomorrow, liverfriends

Strongly encourage other divisions to invite Dr. Rubin to speak #livertwitter

Wonderful to host Dr. Tatyana Kushner this morning. Her experience and knowledge on this subject is tremendous.

Don’t be jealous!

We get to hear from Dr. Tatyana Kushner at Michigan Hepatology and GI grand rounds #livertwitter

Is the diagnosis of HE on the tip of our tongues? Patty Pringle Bloom, M.D. presenting on the HEAR-MHE study where 30 seconds of talking predicts future HE Development

⭐️⭐️ Hepatology Communications Editorial Board is here at AASLD #TLM23 ‼️⭐️⭐️

💥We remain committed to the Respectful, Efficient (🕰️), and Constructive review of your research manuscripts! 📑
#LiverTwitter #OpenAccess

journals.lww.com/hepcomm/pages/…

Phenomenal Starzl lecture from Sumeet Asrani right now

Showing us the rise in alcohol even in google search!

We’re going to have more work to do for ALD…

#TLM23

The EASLnews AASLD Masterclass love lives on!

See you next in Milan 🥳